Cancer Cells Resistant to Therapy Promote Cell Surface Relocalization of GRP78 Which Complexes with PI3K and Enhances PI(3,4,5)P3 Production
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Traditionally, GRP78 has been regarded as an endoplasmic reticulum (ER) lumenal protein due to its carboxyl KDEL retention motif. Recently, a subfraction of GRP78 is found to localize to the surface of specific cell types, serving as co-receptors and regulating signaling. However, the physiological relevance of cell surface GRP78 (sGRP78) expression in cancer and its functional interactions at the cell surface are just emerging. In this report, we combined biochemical, imaging and mutational approaches to address these issues. For detection of sGRP78, we utilized a mouse monoclonal antibody highly potent and specific for GRP78 or epitope-tagged GRP78, coupled with imaging and biochemical techniques that allowed detection of sGRP78 but not intracellular GRP78. Our studies revealed that breast and prostate cancer cells resistant to hormonal therapy actively promote GRP78 to the cell surface, which can be further elevated by a variety of ER stress-inducing conditions. We showed that sGRP78 forms complex with PI3K, and overexpression of sGRP78 promotes PIP3 formation, indicative of PI3K activation. We further discovered that an insertion mutant of GRP78 at its N-terminus domain, while retaining stable expression and the ability to translocate to the cell surface as the wild-type protein, exhibited reduced complex formation with p85 and production of PIP3. Thus, our studies provide a mechanistic explanation for the regulation of the PI3K/AKT signaling by sGRP78. Our findings suggest that targeting sGRP78 may suppress therapeutic resistance in cancer cells and offer a novel strategy to suppress PI3K activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reddy, R. K., Mao, C., Baumeister, P., Austin, R. C., Kaufman, R. J., & Lee, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212328200 · Cited by 695
Self-citationFu, Y., Wey, S., Wang, M., Ye, R., Liao, C.-P., Roy-Burman, P., & Lee, A. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807691105 · Cited by 180 · cited 1×
“not only critically required for prostate tumorigenesis and leukemogenesis, it is also required for AKT activation both in vivo and in vitro [35,49].”
Background
Cited by
Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential
Lee, A. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3701 · Cited by 587
Self-citationEndoplasmic Reticulum Stress and Cancer
Yadav, R. K., Chae, S.-W., Kim, H.-R., & Chae, H. J. (2014) · Journal of Cancer Prevention · doi:10.15430/jcp.2014.19.2.75 · Cited by 393
Zhu, G., & Lee, A. S. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24923 · Cited by 299
Self-citationLiu, Z., Liu, G., Ha, D. P., Wang, J., Xiong, M., & Lee, A. S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303448120 · Cited by 137
“Evidence is emerging that GRP78, in addition to being a potent antiapoptotic protein and a major pro-survival component of the UPR, is a regulator of oncogenic drivers such as PI3K, TGF-β , CD44, and KRAS through direct or indirect interactions (17–19 , 35).”
Self-citationEPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer
Katsyv, I., Wang, M., Song, W. M., Zhou, X., Zhao, Y., Park, S., Zhu, J., Zhang, B., & Irie, H. Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11870 · Cited by 47
Metadata
- Authors
- Zhang, Y., Tseng, C.-C., Tsai, Y.-L., Fu, X., Schiff, R., & Lee, A. S.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-11
- Volume
- 8
- Issue
- 11
- Pages
- e80071
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1994138076
- Cited by
- 149
- References
- 2
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer Cells Resistant to Therapy Promote Cell Surface Relocalization of GRP78 Which Complexes with PI3K and Enhances PI(3,4,5)P3 Production. https://app.cochat.ai/papers/10.1371/journal.pone.0080071
- The paper
- Zhang, Y., Tseng, C.-C., Tsai, Y.-L., Fu, X., Schiff, R., & Lee, A. S. (2013). Cancer Cells Resistant to Therapy Promote Cell Surface Relocalization of GRP78 Which Complexes with PI3K and Enhances PI(3,4,5)P3 Production. PLoS ONE. https://doi.org/10.1371/journal.pone.0080071
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.